Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-057007
Filing Date
2026-08-14
Accepted
2026-08-14 11:50:16
Documents
1
Period of Report
2026-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1786722614.html 4  
1 FORM 4 wk-form4_1786722614.xml 4 5088
  Complete submission text file 0001628280-26-057007.txt   6532
Mailing Address C/O ASPREVA PHARMACEUTICALS CORPORATION 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address
Hayden Michael R (Reporting) CIK: 0001352908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 261278232

Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)